Successful $1.2M Placement and Convertible Note Extended
Open PDF
| Stock | Memphasys Ltd (MEM.ASX) |
|---|---|
| Release Time | 18 Jun 2026, 9:52 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Memphasys Secures $1.2M Placement and Extends Convertible Note
Key Points
- $1.2M capital raise at $0.005 per share
- Strong support from new and existing investors
- Proceeds to support Felix™ commercial execution
- Convertible Note extended to June 2027
Full Summary
Memphasys Ltd (ASX: MEM) announced a successful $1.2M capital raise through a share placement at $0.005 per share, strongly supported by new and existing investors. The funds will support the commercial execution of the Felix™ system, including expanding the direct selling model and manufacturing cartridges to meet growing demand. Additionally, the company extended the repayment terms of its convertible note with Peters Investments by 12 months to June 2027, providing financial flexibility for its commercial strategy.
Guidance
Memphasys Ltd aims to use $1.2M raised from the placement to support Felix™ commercial execution.
Outlook
Memphasys Ltd is well-positioned to scale its commercial activities with the new funds and extended convertible note terms.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In